Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, announced the sta ...

The announcement followed the company receiving Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA).

SirPAD is an investigator-initiated, multi-centre, randomized, open-label trial that aims to determine whether the MagicTouch PTA sirolimus-coated balloon is non-inferior to plain old balloon ...